111In-3BP tracer

N/A

Report date: 2025/01/26 19:27:29

Base Information

Drug Name111In-3BP tracer
Drug Alias NameGIPR antagonist (3B Pharmaceuticals)glucose dependent insulinotropic polypeptide receptor antagonist (3B Pharmaceuticals)
ClassificationRadiation-emitting productsBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor antagonists
TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbH
Inactive CompaniesN/A
Active IndicationsNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A